RESHAPE LIFESCIENCES INC.

Analyst Reco. ReShape Lifesciences Inc.

Equities

RSLS

US76090R2004

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-20 EDT			5-day change	1st Jan Change
0.1884 ^USD	-4.12%		-7.60%	-24.55%

05-15	ReShape Lifesciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-15	Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Maxim Group Adjusts ReShape Lifesciences Price Target to $1.50 From $3, Maintains Buy Rating	22-08-01	MT
Alliance Global Adjusts Price Target on ReShape Lifesciences to $4.65 From $5.50, Reiterates Buy Rating	22-05-26	MT
Maxim Lowers Price Target for ReShape Lifesciences to $4 From $8, Maintains Buy Rating	22-03-29	MT
Alliance Global Adjusts Price Target on ReShape Lifesciences to $5.50 From $10.25, Reiterates Buy Rating	22-03-29	MT
RESHAPE LIFESCIENCES : Maxim Group Initiates Coverage on ReShape Lifesciences With Buy Rating, $8 Price Target	21-10-08	MT
RESHAPE LIFESCIENCES : Alliance Global Partners Adjusts ReShape Lifesciences PT to $13.75 From $18.50, Maintains Buy Rating	21-06-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer